In this study, we aim to systematically investigate the clinicopathological significance of WIF-1 promoter hypermethylation and NSCLC and quantify the association between WIF-1 promoter hypermethylation and NSCLC using meta-analysis methods. Here, WIF1 is linked to non-small cell lung carcinoma.